Research / AVGO / Fundamental state Inspectable configuration
State dimensions Filing 0001730168-19-000036 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
650.22% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.71% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
36.83% · OPTIONAL · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
18.55% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
55.42% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
9.59% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
19.57% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
8.03% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 23 states Self-history eligible
Feb 3, 2019 0/8 normalized Level 3 May 5, 2019 0/9 normalized Level 3 Aug 4, 2019 0/9 normalized Level 3 Nov 3, 2019 0/9 normalized Level 3 Feb 2, 2020 0/9 normalized Level 3 May 3, 2020 6/9 normalized Level 3 Aug 2, 2020 8/9 normalized Level 3 Nov 1, 2020 8/9 normalized Level 3 Jan 31, 2021 8/9 normalized Level 3 May 2, 2021 9/9 normalized Level 3 Aug 1, 2021 9/9 normalized Level 3 Oct 31, 2021 9/9 normalized Level 3 Jan 30, 2022 9/9 normalized Level 3 May 1, 2022 9/9 normalized Level 3 Jul 31, 2022 9/9 normalized Level 3 Oct 30, 2022 8/8 normalized Level 3 Jan 29, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Jul 30, 2023 8/8 normalized Level 3 Aug 2, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 83.91%
Current 650.22%
Delta 566.31% Capex Intensity Decreased
Previous 3.05%
Current 1.71%
Delta -1.34% Cash Generation Decreased
Previous 42.59%
Current 36.83%
Delta -5.77% Inventory Pressure Increased
Previous 5.39%
Current 18.55%
Delta 13.16% Margin Increased
Previous 51.48%
Current 55.42%
Delta 3.93% Profitability Decreased
Previous 24.63%
Current 9.59%
Delta -15.04% R And D Intensity Increased
Previous 18.07%
Current 19.57%
Delta 1.50% Sbc Intensity Increased
Previous 5.89%
Current 8.03%
Delta 2.15% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.